Phosphorylation of human DNMT1: Implication of cyclin-dependent kinases

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 187-192

  Lavoie, Geneviève ^a   St Pierre, Yves ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Cyclin dependent kinase; DNA methylation; DNA methyltransferase 1; Protein phosphorylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 5; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; ROSCOVITINE; SERINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL DIVISION; CELL STRAIN HEK293; DNA METHYLATION; EMBRYO; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; WILD TYPE;

CDC2 PROTEIN KINASE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 5; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME STABILITY; EPIGENESIS, GENETIC; HEK293 CELLS; HUMANS; NEOPLASMS; PHOSPHORYLATION; SERINE;

EID: 79957927567     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.115     Document Type: Article

References (28)

1. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69:915-926.
2. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
3. Pradhan S., Bacolla A., Wells R.D., Roberts R.J. Recombinant human DNA (cytosine-5) methyltransferase.I. Expression, purification, and comparison of de novo and maintenance methylation. J. Biol. Chem. 1999, 274:33002-33010.
4. Chuang L.S., Ian H.I., Koh T.W., Ng H.H., Xu G., Li B.F. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 1997, 277:1996-2000.
5. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 2000, 25:269-277.
6. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 2000, 25:338-342.
7. Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 2004, 101:12130-12135.
8. Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2007, 104:2199-2204.
9. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. USA 2008, 105:10762-10767.
10. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010, 3:ra3.
11. E. Hervouet, L. Lalier, E. Debien, M. Cheray, A. Geairon, H. Rogniaux, D. Loussouarn, S.A. Martin, F.M. Vallette, and P.F. Cartron, Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS ONE 5(2010) e11333.
12. Esteve P.O., Chang Y., Samaranayake M., Upadhyay A.K., Horton J.R., Feehery G.R., Cheng X., Pradhan S. A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability. Nat Struct Mol Biol 2011, 18:42-48.
13. Morgan D.O. The Cell Cycle Principles of Control 2007, New Science Press, London.
14. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
15. Brown N.R., Noble M.E., Endicott J.A., Johnson L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell. Biol. 1999, 1:438-443.
16. Holmes J.K., Solomon M.J. A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2. J. Biol. Chem. 1996, 271:25240-25246.
17. Meijer L., Borgne A., Mulner O., Chong J.P., Blow J.J., Inagaki N., Inagaki M., Delcros J.G., Moulinoux J.P. Biochemical and cellular effects of a potent and selective inhibitor of the cyclin-dependent kinases cdc2,cdk2 and cdk5. Eur. J. Biochem. 1997, 243:527-536.
18. Goyal R., Rathert P., Laser H., Gowher H., Jeltsch A. Phosphorylation of serine-515 activates the Mammalian maintenance methyltransferase Dnmt1. Epigenetics 2007, 2:155-160.
19. K.T. Rigbolt, T.A. Prokhorova, V. Akimov, J. Henningsen, P.T. Johansen, I. Kratchmarova, M. Kassem, M. Mann, J.V. Olsen, and B. Blagoev, System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4 rs3.
20. Koundrioukoff S., Jonsson Z.O., Hasan S., de Jong R.N., van der Vliet P.C., Hottiger M.O., Hubscher U. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation. J. Biol. Chem. 2000, 275:22882-22887.
21. Prosperi E. The fellowship of the rings: distinct pools of proliferating cell nuclear antigen trimer at work. FASEB J. 2006, 20:833-837.
22. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
23. D'Aiuto L., Marzulli M., Mohan K.N., Borowczyk E., Saporiti F., Vandemark A., Chaillet J.R. Dissection of structure and function of the N-terminal domain of mouse DNMT1 using regional frame-shift mutagenesis. PLoS ONE 2010, 5:e9831.
24. Fatemi M., Hermann A., Pradhan S., Jeltsch A. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA. J. Mol. Biol. 2001, 309:1189-1199.
25. Zimmermann C., Guhl E., Graessmann A. Mouse DNA methyltransferase (MTase) deletion mutants that retain the catalytic domain display neither de novo nor maintenance methylation activity in vivo. Biol. Chem. 1997, 378:393-405.
26. Bacolla A., Pradhan S., Larson J.E., Roberts R.J., Wells R.D. Recombinant human DNA (cytosine-5) methyltransferase. III.Allosteric control reaction order, and influence of plasmid topology and triplet repeat length on methylation of the fragile X CGG.CCG sequence. J. Biol. Chem. 2001, 276:18605-18613.
27. Margot J.B., Ehrenhofer-Murray A.E., Leonhardt H. Interactions within the mammalian DNA methyltransferase family. BMC. Mol. Biol. 2003, 4:7.
28. Ghoshal K., Datta J., Majumder S., Bai S., Kutay H., Motiwala T., Jacob S.T. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box,bromo-adjacent homology domain and nuclear localization signal. Mol. Cell. Biol. 2005, 25:4727-4741.